National Natural Science Foundation of China: Report the results of 15 misconduct cases!

On April 12, the National Natural Science Foundation of China issued a total of 15 notices on the results of the handling of misconduct cases in 2024 (the first batch). It involved 15 colleges and universities, including Xi'an Jiaotong University, Tongji University, Central South University, and Shandong University, and dealt with 21 people, mainly involving problems such as asking for entrustment and greetings, arbitraging funds, plagiarizing and plagiarizing other people's fund applications, buying and selling papers and falsifying pictures, and fictitious authors. Relevant personnel will be disqualified from applying for the National Natural Science Foundation of China and participating in the application for 2-5 years.

2024 Misconduct Case Handling Results Notification

(1st Batch)

Recently, after the investigation and deliberation of the Supervisory Committee of the National Natural Science Foundation of China and the approval of the committee meeting of the National Natural Science Foundation of China, the National Natural Science Foundation of China has dealt with the subjects involved in the relevant scientific research misconduct cases. In accordance with relevant provisions, the relevant facts of the case and the outcome of the handling are hereby reported.

1. The Supervisory Committee of the National Natural Science Foundation of China conducted an investigation into the suspected academic misconduct of Beijing University of Civil Engineering and Architecture.

　　After investigation, in 2022, the season organized an online meeting, arranged for relevant personnel to collect information on possible fund project review experts, and contacted some experts by Ji Ji and others after the meeting, and in 2023, the season asked a number of potential review experts for the key projects he applied for (unfunded) through phone calls, text messages, WeChat and other forms.

　　If there is a problem of interfering with the order of the evaluation of the fund project, which violates the agreement of the "Letter of Commitment of the Applicants and Participants of the National Natural Science Foundation of China", the season shall be responsible for the above problems.

　　After the deliberation of the second meeting of the sixth session of the Supervisory Committee of the National Natural Science Foundation of China, and the approval of the 21st committee meeting of the National Natural Science Foundation of China in 2023, it was decided to follow the measures for the investigation and handling of scientific research misconduct in accordance with Article 44, Paragraphs 1 and 4, In the second paragraph of Article 50, the qualifications for applying for and participating in seasonal projects of the National Natural Science Foundation of China shall be cancelled for 3 years (December 26, 2023 to December 25, 2026), and the qualifications for the evaluation of seasonal projects of the National Natural Science Foundation of China shall be cancelled for 5 years (December 26, 2023 to December 25, 2028), and the seasonal notice will be criticized.

2. The Supervisory Committee of the National Natural Science Foundation of China conducted an investigation into Yang Lijun of North China Electric Power University on suspicion of academic misconduct.

　　After investigation, Yang Lijun applied for key projects of the National Natural Science Foundation of China for two consecutive years in 2022 and 2023 (none of which were funded), and asked a number of potential review experts by sending emails and other means.

　　Yang Lijun has violated the provisions of the Letter of Commitment of Applicants and Participants of the National Natural Science Foundation of China, and Yang Lijun should be responsible for the above problems.

3、国家自然科学基金委员会监督委员会对宁夏医科大学成江发表的论文“Jiang Cheng#, et al. Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling. Translational neuroscience. 2022; 13: 407.（标注基金号81960245）。 ”涉嫌学术不端开展了调查。

　　After investigation, the paper involved had the problems of buying and selling experimental research data, using other people's signatures without consent, and marking fund projects in scientific research results unrelated to science fund projects. The first author, Cheng Jiang, should be responsible for the above problems. In addition, Cheng Jiang included the paper in the progress report of the fund project (approval number 81960245), and Cheng Jiang should also be responsible for this issue.

　　After the deliberation of the second meeting of the sixth session of the Supervisory Committee of the National Natural Science Foundation of China, and the approval of the 21st committee meeting of the National Natural Science Foundation of China in 2023, it was decided to cancel the Chengjiang National Natural Science Foundation project in accordance with Article 47, Article 42, Paragraph 2, Article 43, Paragraphs 1 and 8, and Article 46 of the Measures for the Investigation and Handling of Scientific Research Misconduct of National Natural Science Foundation of China" The regulatory mechanism of TfR1 on the mitochondrial inner membrane protein frataxin in the neural differentiation of Alzheimer's disease-iPS cells" (Approval No. 81960245), recovered the allocated funds, cancelled the application for the National Natural Science Foundation of Chengjiang and the qualification to participate in the application for 5 years (December 26, 2023 to December 25, 2028), and gave Chengjiang a notice of criticism.

4、国家自然科学基金委员会监督委员会对杭州医学院汪霄、陈哲灵等发表的论文“Xiao Wang#, Zheling Chen*, et al. Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling. Gene. 2020,722: 144057.” （标注基金号81802623）涉嫌学术不端开展了调查。

　　After investigation, the paper involved was obtained from the sale, and the signatures of the two co-first authors were used without the consent of the two co-first authors, and Wang Xiao, the first author of the paper, and Chen Zheling, the corresponding author, should be responsible for the above problems.

　　It was decided to revoke Chen Zheling's National Natural Science Foundation of China project "Research on the Mechanism of Rho Mediating Breast Cancer Invasion and Metastasis by Regulating MYH9" in accordance with Article 47, Article 42, Paragraph 2, and Article 43, Paragraph 1 of the Measures for the Investigation and Handling of Scientific Research Misconduct of National Natural Science Foundation of China (Approval No. 81802623), recover the allocated funds, cancel Chen Zheling's application for the National Natural Science Foundation of China and his qualifications to participate in the application for 3 years (December 26, 2023 to December 25, 2026), and give Chen Zheling a notice of criticism.

5. The Supervisory Committee of the National Natural Science Foundation of China conducted an investigation into the suspected academic misconduct of two papers published by Zhang Zhongqiang and Tan Xiao of Central South University, and the papers involved are as follows:

　　论文1：Zhongqiang Zhang, Xiao Tan, JingShan Tong*, et al. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Cell death & disease, 2020, 11(10): 1-14.（标注基金号81900371）

　　论文2：Xiao Tan, Zhongqiang Zhang, et al. Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway. Cancer Letters, 2018, 436: 119-128.

　　After investigation, some of the pictures in paper 1 are the same as some of the pictures in multiple papers by different people in multiple units but represent different meanings, the pictures involved are from a third party, and the paper has the problem of picture plagiarism; Zhang Zhongqiang, the first author of paper 1, Tong Jingshan, the corresponding author, Tan Xiao, the first author of paper 2, and Tong Jingshan, who provided the pictures involved, should be responsible for the objective results of the problems in the paper.

　　In addition, Zhang Zhongqiang included paper 1 in the progress report of the fund project (approval number 81900371) and the application for the fund project (application number 8227033919), and Tan Xiao included paper 2 in the application for the fund project (approval number 82002616), and Zhang Zhongqiang and Tan Xiao should also be responsible for this issue respectively.

　　It was decided to revoke Tan Xiao's National Natural Science Foundation project "Research on the Mechanism of BET Degraders in Improving the Efficacy of Colorectal Cancer by Inducing DR5-Dependent Cell Killing and Anti-tumor Immunity" in accordance with Article 40 of the Measures for the Investigation and Handling of Scientific Research Misconduct in National Natural Science Foundation of China (Approval No. 82002616), recover the allocated funds, cancel Tan Xiao's application for the National Natural Science Foundation of China and his qualifications to participate in the application for 5 years (December 26, 2023 to December 25, 2028), and give Tan Xiao a notice of criticism.

6. The Supervisory Committee of the National Natural Science Foundation of China has investigated two papers related to Tong Jingshan of Xuzhou Medical University (who worked in Xuzhou Medical University after returning to China) and others for suspected academic misconduct, and the papers involved are as follows:

7、国家自然科学基金委员会监督委员会对同济大学李明等发表的论文“Ming Li, et al. Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3[J]. Scientific Reports. 2016;6:23100.（标注基金号81372175、81172229）”涉嫌学术不端开展了调查。

　　After investigation, the paper involved had problems of chaotic use of pictures, such as repetition within or between pictures, and the problems of not being able to provide all the original data, marking other people's science fund projects without authorization, using others' signatures without consent, and false corresponding authors and co-authors. In addition, another retracted paper by Li Ming (Li M, et al. PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer. J. Cancer 2017; 8(10): 1795-1800.) There are also problems of unauthorized labeling of other people's science fund projects and the use of others' signatures without consent. Li Ming should be held responsible for the above problems.

8. The Supervisory Committee of the National Natural Science Foundation of China has conducted an investigation into the suspected academic misconduct of two papers published by Shen Shining and others of Zhengzhou University, and the papers involved are as follows:

　　论文1：Si-Ning Shen*, et al. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1. Mol Oncol. 2019; 13(12):2554-2573.（标注基金号81201954）

　　论文2：Si-Ning Shen*, et al. Silencing lncRNAs PVT1 Upregulates miR-145 and Confers Inhibitory Effects on Viability, Invasion, and Migration in EC. Mol Ther Nucleic Acids. 2020;19:668-682.（标注基金号81201954）

　　After investigation, the two papers were found to have the problems of repeated publication and tampering with experimental research data and charts, and there were also problems of marking other people's science fund projects without authorization and listing others as the authors of the papers without authorization, and Shen Sining, the first and corresponding author of the two papers, should be responsible for the above problems.

　　After the deliberation of the second meeting of the sixth session of the Supervisory Committee of the National Natural Science Foundation of China, and the approval of the 21st committee meeting of the National Natural Science Foundation of China in 2023, it was decided to follow the "Measures for the Investigation and Handling of Scientific Research Misconduct in National Natural Science Foundation Projects" Article 47, Article 40, Article 42, Paragraph 1 of Article 43, Sixth, Shen Sining's application for the National Natural Science Foundation of China and his qualifications to participate in the application for 5 years (December 26, 2023 to December 25, 2028) will be cancelled, and Shen Sining will be given a notice of criticism.

9. The Supervisory Committee of the National Natural Science Foundation of China conducted an investigation into Wu Yu of Fujian Medical University on suspicion of academic misconduct.

　　After investigation, Wu Yu obtained some experimental data and pictures of others during academic exchanges, and when writing his application for the 2023 fund project (application number 8237100127), he directly marked the experimental data, pictures and other achievements of others as the experimental results related to the application project, and wrote them into the application form as a "research basis". Wu Yu has the problem of plagiarizing the research results of others and falsifying the research basis of the application, and should be responsible for the above problems.

10. The Supervisory Committee of the National Natural Science Foundation of China conducted an investigation into a number of papers published by Wang Chuanxin and others of Shandong University on suspicion of academic misconduct, including:

　　论文1：Chuanxin Wang*, et al. Leptin-mediated regulation of MT1-MMP localization is KIF1B dependent and enhances gastric cancer cell invasion. Carcinogenesis, 2013,34(5)：974-983. （标注基金号31270971、81072406、30672010）

　　论文2：Chuanxin Wang*, et al. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer, 2019, 18(1):43.（标注基金号81472025、81772271）

　　论文3：Chuanxin Wang*, et al. MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer. PLoS ONE, 2015, 10(2): e0118086.（标注基金号81271916)

　　论文4：Chuanxin Wang*, et al. MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity. PLoS ONE.2015, 10(1): e0116170.（标注基金号81072406、81271916、31270971、81301506）

　　论文5：Chuanxin Wang*, et al. Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer. PLoS ONE, 2014, 9(3): e90952.（标注基金号81271916、81301506）

　　论文6：Chuanxin Wang*, et al. Aberrant CCR4 expression is involved in tumor invasion of lymph node-negative human gastric cancer. PLoS One, 2015, 10(3): e0120059. （标注基金号81271916、81301506）

　　After investigation, the above papers have the problems of chaotic use of pictures and non-standard management of experimental raw data (patient follow-up records, etc.), and the corresponding authors Wang Chuanxin and others should be responsible for the problems in the papers involved. In addition, Wang Chuanxin included paper 1, paper 3 and paper 5 in the application for the fund project (approval number 81772271), paper 1 in the application for the fund project (approval number 81472025), paper 2 in the application for the fund project (approval number 82130067) and the final report of the fund project (approval number 81772271), and paper 3 in the progress report and final report of the fund project (approval number 81271916), and Wang Chuanxin should also be responsible for this problem.

　　After the deliberation of the second meeting of the sixth session of the Supervisory Committee of the National Natural Science Foundation of China and the approval of the 21st committee meeting of the National Natural Science Foundation of China in 2023, it was decided to revoke Wang Chuanxin's National Natural Science Foundation project "Research on the Screening, Verification and Serological Diagnostic Value of lncRNAs Related to the Occurrence of Colorectal Cancer" (Grant No. 81472025) in accordance with Articles 47, 40 and 46 of the Measures for the Investigation and Treatment of Scientific Research Misconduct in National Natural Science Foundation of China. "Construction and Application of Diagnostic and Prognostic Model for Colorectal Cancer Based on Serosecretory circRNAs" (Grant No. 81772271), "Construction and Clinical Application of Bladder Cancer Diagnosis and Staging Prediction Model Based on Differential Expression Profiling of Urine miRNAs" (Grant No. 81271916) and "Construction of Exosome Detection Platform Based on 3D Nanopillar Array Microfluidic Chip and Its Application in Early Diagnosis of Colorectal Cancer" (Approval No. 82130067), recover the allocated funds of the above 4 projects, cancel Wang Chuanxin's application for the National Natural Science Foundation of China and his qualifications to participate in the application for 5 years (December 26, 2023 to December 25, 2028), and give Wang Chuanxin a notice of criticism.

11、国家自然科学基金委员会监督委员会对中国医科大学韩帅、李付勇等发表的论文“Shuai Han, Fuyong Li*, et al. SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway. J Exp Clin Cancer Res, 2020, 39(1):218.” 涉嫌学术不端开展了调查。

　　After investigation, it was found that there were multiple pictures in the papers involved that were the same as all or part of the pictures in multiple papers by multiple units, but they represented different meanings, and there was a problem of confusion in the use of pictures. The first author, Han Shuai, and the corresponding author, Li Fuyong, should be responsible for the above problems. In addition, Han Shuai included the paper in question in the application for the fund project (approval number 32200608), and Li Fuyong included the paper in the application for the fund project (application number 8217102682), and Han Shuai and Li Fuyong should also be responsible for this issue.

　　It was decided that in accordance with Article 40 of the Measures for the Investigation and Handling of Scientific Research Misconduct in National Natural Science Foundation of China Projects, Li Fuyong's application and participation in the National Natural Science Foundation of China project application and participation in the application were cancelled for 3 years (December 26, 2023 to December 25, 2026), and Li Fuyong was given a notice of criticism.

12. The Supervisory Committee of the National Natural Science Foundation of China conducted an investigation into the suspected academic misconduct of the paper published by Zhang Cong and others of Jiangnan University. The papers involved are as follows:

　　论文1：Cong Zhang*, Toshiyuki Bangi, et al. Evaluation of pseudo-strain hardening behavior of hybrid fiber reinforced ultra-high performance concrete containing coarse aggregates by using micromechanical principles. Journal of Building Engineering, 2022, 61: 105234.（标注基金号51908247）

　　论文2：Cong Zhang*, Toshiyuki Bangi, et al. Influence of distribution modulus on the compressive strength of ultra-high-performance concrete with coarse aggregate (UHPC-CA). Advances in Civil Engineering, 2022, 2022: 7615616.（标注基金号51908247）

　　论文3：Cong Zhang*, Toshiyuki Bangi, et al. Mechanical properties, durability and application of ultra-high-performance concrete containing coarse aggregate (UHPC-CA): a review. Construction and Building Materials, 2022, 334: 127360.（标注基金号51908247）

　　论文4：Cong Zhang*, Toshiyuki Bangi, et al. Investigation of SAP content on the shrinkage and tensile properties of ultra-high performance concrete. Construction and Building Materials, 2022, 345: 128402.（标注基金号51908247）

　　论文5：Cong Zhang*, Toshiyuki Bangi, et al. Influence of eco-friendly fine aggregate on macroscopic properties, microstructure and durability of ultra-high performance concrete: a review. Journal of Building Engineering, 2023, 65: 105783.（标注基金号51908247）

　　论文6：Cong Zhang*, Toshiyuki Bangi, et al. Effect of CaCO3 whiskers on tensile properties of ultra-high-performance engineered cementitious composites. Journal of Building Engineering, 2022, 57: 104896.（标注基金号51908247）

　　论文7：Cong Zhang*, Toshiyuki Bangi, et al. Experimental study and theoretical modeling for the flexural property of multi-scale hybrid fiber reinforced SHCC. Case Studies in Construction Materials, 2022, 16: e01083.（标注基金号51908247）

　　论文8：Cong Zhang*, Toshiyuki Bangi, et al. Shrinkage and tensile properties of ultra-high-performance engineered cementitious composites (UHP-ECC) containing superabsorbent polymers (SAP) and united expansion agent (UEA). Construction and Building Materials, 2022, 339: 127697.（标注基金号51908247）

　　论文9：Cong Zhang*, Toshiyuki Bangi, et al. Design approach, mechanical properties and cost-performance evaluation of ultra-high performance engineered cementitious composite (UHP-ECC): a review. Construction and Building Materials, 2022, 340: 127734.（标注基金号51908247）

　　论文10：Cong Zhang*, Toshiyuki Bangi, et al. Mechanical properties and assessment of a hybrid ultra-high-performance engineered cementitious composite using calcium carbonate whiskers and polyethylene fibers. Computers and Concrete, 2022, 30: 339-355.（标注基金号51908247）

　　论文11：Cong Zhang*, Toshiyuki Bangi, et al. Effect of crushed granite, superabsorbent polymer, and expansive agent on the workability, compressive properties, and autogenous shrinkage of ultrahigh-performance concrete. Journal of Materials in Civil Engineering, 2023, 23: 04023050.（标注基金号51908247）

　　论文12：Zhang C*, Shen Y, et al. Experimental study and theoretical modeling for the compressive stress-strain relationship of multi-scale hybrid fiber-reinforced SHCC. Materiales De Construccion, 2022, 72: e272.（标注基金号51908247）

　　After investigation, Zhang Cong, the corresponding author of papers 1-11, had the problem of fictitious Nanyang Technological University Bangi Toshiyuki as the authorship of papers 1-11. Zhang Cong, the first and corresponding author of paper 12, has the problem of fictionalizing Nanyang Technological University Shen Y as the authorship of paper 12, and Zhang Cong should be responsible for the above problem.

13. The Supervisory Committee of the National Natural Science Foundation of China conducted an investigation into the suspected academic misconduct of papers published by Liu Zhikui, Liu Qingguang, Tu Kangsheng, Yang Nan and others of Xi'an Jiaotong University. The papers involved are as follows:

　　论文1：Zhikui Liu#, Kangsheng Tu*, Qingguang Liu*, et al. Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma. Oncotarget. 2016; 7(18):25350-65.（标注基金号81272645、81402039、81572847）。

　　论文2：Zhikui Liu#, Kangsheng Tu*, Qingguang Liu*, et al. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma. European Journal of Medicinal Chemistry. 2018;145:338-349.（标注基金号81272645、81402039、81502092、81572847）。

　　论文3：Nan Yang*, et al. ZKSCAN3 drives tumor metastasis via integrin β4/FAK/AKT mediated epithelial–mesenchymal transition in hepatocellular carcinoma. Cancer Cell International. 2020;20:216.（标注基金号81773123、81874069）。

　　论文4：Zhikui Liu#, Qingguang Liu*, Kangsheng Tu*, et al. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 2018; 37(1):49.（标注基金号81773123、81572847、81502092）。

　　After investigation, papers 1, 2 and 4 have problems such as plagiarism, improper manipulation of pictures, and confusion in the use of pictures, and paper 3 has problems such as duplication of pictures in other people's papers. The first author of paper 1, Liu Zhikui, the corresponding author Liu Qingguang, and the co-corresponding author Tu Kangsheng, the first author of paper 2, Liu Zhikui, the corresponding author Liu Qingguang, and the co-corresponding author Tu Kangsheng, the corresponding author of paper 3, Yang Nan, the first author of paper 4, Liu Zhikui, the corresponding author Tu Kangsheng, and the co-corresponding author Liu Qingguang are respectively responsible for the problems existing in the corresponding papers. In addition, Liu Zhikui should also be responsible for the unauthorized labeling of other people's fund projects and paper 4 and the unauthorized use of others' signatures in papers 4; Yang Nan should also be responsible for the unauthorized labeling of other people's fund projects in paper 3; Liu Qingguang, Tu Kangsheng, and Liu Zhikui should also be responsible for including the papers involved in the fund project application or progress and final report.

　　It was decided to revoke Liu Qingguang's National Natural Science Foundation of China project "Research on the molecular mechanism of Sulfatase2 regulating the tumor microenvironment of hepatocellular carcinoma through the Hedgehog/GLI1 pathway" (Grant No. 81272645) and "Mechanism study of VASP regulating the invasion and metastasis of hepatocellular carcinoma in the hypoxic tumor microenvironment" in accordance with Articles 47, 40 and 46 of the Measures for the Investigation and Treatment of Scientific Research Misconduct of National Natural Science Foundation of China (Approval No. 81572847), recover the allocated funds of the above two projects, cancel Liu Qingguang's application for the National Natural Science Foundation of China and his qualifications to participate in the application for 2 years (December 26, 2023 to December 25, 2025), and give Liu Qingguang a notice of criticism.

　　It was decided to revoke Tu Kangsheng's National Natural Science Foundation of China project "Mechanism of Activation and Secretion of COMP in Extracellular Matrix High Hardness Microenvironment to Promote the Progression of Hepatocellular Carcinoma" (Grant No. 81773123) and "Fbxw7 Induces Apoptosis and Growth Arrest of Hepatocellular Cancer Cells by Ubiquitinated Proteolysis of YAP Protein by Ubiquitinated Proteolysis" in accordance with Articles 47, 40 and 46 of the Measures for the Investigation and Treatment of Scientific Research Misconduct of National Natural Science Foundation of China (Approval No. 81402039), recover the allocated funds of the above two projects, cancel Tu Kangsheng's application for the National Natural Science Foundation of China and his qualifications to participate in the application for 2 years (December 26, 2023 to December 25, 2025), and give Tu Kangsheng a notice of criticism.

　　It was decided to cancel Yang Nan's application and participation in the National Natural Science Foundation of China project for 2 years (December 26, 2023 to December 25, 2025) in accordance with Articles 47, 40 and Article 43, Item 6 of the Measures for the Investigation and Handling of Scientific Research Misconduct in National Natural Science Foundation of China, and give Yang Nan a notice of criticism.

14. The Supervisory Committee of the National Natural Science Foundation of China launched an investigation into Li Xiao of Shenzhen University on suspicion of academic misconduct.

　　After investigation, Li Xiao used a large number of other people's fund project applications without the knowledge of others to write his own application for 2023 fund projects (application number 8237162197). Li Xiao has the problem of plagiarism and plagiarism of the content of other people's fund project applications, and Li Xiao should be responsible for the above problems.

15. The National Natural Science Foundation of China (NSFC) investigated Chi Guotai of Dalian University of Technology on suspicion of illegal use of funds for science fund projects.

　　After investigation, Chi Guotai obtained funds for key projects of the Science Foundation (approval number 71731003 by recovering labor fees from students, and the circumstances were more serious, violating the relevant provisions of the "Measures for the Management of Funds for Projects Funded by the National Natural Science Foundation of China", and Chi Guotai, as the person in charge of the project, should be responsible for the above problems.

　　After the approval of the first committee meeting of the National Natural Science Foundation of China in 2024, it was decided to revoke the project of Chi Guotai National Natural Science Foundation of China "Research on the Theory and Method of Micro Credit Evaluation in the Big Data Environment" in accordance with Item 5 of Article 35 of the Regulations of the National Natural Science Foundation of China and Item 4 of Article 45 of the Measures for the Investigation and Handling of Scientific Research Misconduct of National Natural Science Foundation Projects (Approval No. 71731003), recover the allocated funds, cancel Chi Guotai's National Natural Science Foundation project application and participation in the application for 5 years (January 9, 2024 to January 8, 2029), and give Chi Guotai a notice of criticism.

Source: National Natural Science Foundation of China.

National Natural Science Foundation of China: Report the results of 15 misconduct cases!

Read on